Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Elisa Marabotto Giorgia Bodini |
| Publication date | September 10, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |